Burning Rock Biotech Limited (BNR) Free cash flow 2020–2025
Burning Rock Biotech Limited (BNR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$4.8MFY2025 · since FY2020: -$20.5M → -$4.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.8M | +64.0% |
| FY2024 | -$13.4M | +64.0% |
| FY2023 | -$37.2M | +50.6% |
| FY2022 | -$75.2M | +29.7% |
| FY2021 | -$107.1M | -422.0% |
| FY2020 | -$20.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice